Enliven Therapeutics shares owned by Mirae Asset Global Investments
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Mirae Asset Global Investments
from 13F filings
Historical chart of Mirae Asset Global Investments investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Enliven Therapeutics by Mirae Asset Global Investments
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $41k | 1.7k | 24.13 |
2024-06-30 | $33k | 1.4k | 23.45 |
2023-12-31 | $170k | 12k | 13.84 |
2023-09-30 | $154k | 11k | 13.66 |
2023-06-30 | $230k | 11k | 20.41 |
More positions owned by Mirae Asset Global Investments
View all positions for Mirae Asset Global Investments